Bozzarelli, I.; Orsini, A.; Isidori, F.; Mastracci, L.; Malvi, D.; Lugaresi, M.; Fittipaldi, S.; Gozzellino, L.; Astolfi, A.; Räsänen, J.;
et al. miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma. Cancers 2024, 16, 591.
https://doi.org/10.3390/cancers16030591
AMA Style
Bozzarelli I, Orsini A, Isidori F, Mastracci L, Malvi D, Lugaresi M, Fittipaldi S, Gozzellino L, Astolfi A, Räsänen J,
et al. miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma. Cancers. 2024; 16(3):591.
https://doi.org/10.3390/cancers16030591
Chicago/Turabian Style
Bozzarelli, Isotta, Arianna Orsini, Federica Isidori, Luca Mastracci, Deborah Malvi, Marialuisa Lugaresi, Silvia Fittipaldi, Livia Gozzellino, Annalisa Astolfi, Jari Räsänen,
and et al. 2024. "miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma" Cancers 16, no. 3: 591.
https://doi.org/10.3390/cancers16030591
APA Style
Bozzarelli, I., Orsini, A., Isidori, F., Mastracci, L., Malvi, D., Lugaresi, M., Fittipaldi, S., Gozzellino, L., Astolfi, A., Räsänen, J., D’Errico, A., Rosati, R., Fiocca, R., Seri, M., Krishnadath, K. K., Bonora, E., & Mattioli, S.
(2024). miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma. Cancers, 16(3), 591.
https://doi.org/10.3390/cancers16030591
